The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) is tasked with providing objective oversight to protect the integrity and promote the efficiency of Medicare, Medicaid, and more than 100 other federal healthcare programs, as well as the health and welfare of the people they serve.

Bass, Berry & Sims is pleased to share its second annual HHS-OIG Year in Review, a novel industry resource highlighting key OIG guidance issued in 2023, including:

• The new General Compliance Program Guidance.
• The expanded informal FAQ process.
• The new civil monetary penalties for information blocking.
• OIG’s strategic plan for managed care oversight.
• A consumer alert regarding remote patient monitoring.
• The end of the public health emergency declaration.
• OIG’s new telehealth toolkit.
• Significant advisory opinions.
• Significant SDP settlements.
• Litigation against OIG challenging unfavorable advisory opinions.

We hope that this tool will assist you in understanding how OIG frames and analyzes fraud and abuse issues so that you can assess and manage risk as you navigate the ever dynamic healthcare regulatory environment.